Alpine Woods Capital Investors’s Cardiovascular Systems, Inc. CSII Stock Holding History

Alpine Woods Capital Investors’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-12,020	Closed	-$379K	–	264
2020 Q2	$379K	Sell	12,020 -100	-0.8%	-$3.73K	0.07%	200
2020 Q1	$427K	Hold	12,120	–	–	0.1%	180
2019 Q4	$589K	Hold	12,120	–	–	0.11%	166
2019 Q3	$576K	Buy	12,120 +2,000	+20%	+$94K	0.11%	155
2019 Q2	$434K	Hold	10,120	–	–	0.09%	195
2019 Q1	$391K	Buy	+10,120	New	+$343K	0.09%	195
2014 Q1	–	Sell	-9,000	Closed	-$308K	–	465
2013 Q4	$308K	Buy	+9,000	New	+$262K	0.02%	325

Other funds holding CSII

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Alpine Woods Capital Investors's CSII Position: Q3 2020 in Review

Alpine Woods Capital Investors sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2020, closing a stake of 12,020 shares — an estimated $379K sold.

Alpine Woods Capital Investors first reported a position in CSII in Q4 2013 and held it in 7 quarters. The position peaked at $589K in Q4 2019. 186 funds tracked by Wall St. Rank hold CSII as of Q3 2020.

Alpine Woods Capital Investors reported no remaining Cardiovascular Systems, Inc. position as of Q3 2020 after selling out during the quarter.
Alpine Woods Capital Investors sold 12,020 Cardiovascular Systems, Inc. shares in Q3 2020, an estimated $379K.
Alpine Woods Capital Investors first reported a position in Cardiovascular Systems, Inc. in Q4 2013 and held it in 7 quarters.
Alpine Woods Capital Investors's Cardiovascular Systems, Inc. position peaked at $589K in Q4 2019.
186 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2020.

Based on Alpine Woods Capital Investors's 13F filing for Q3 2020, filed 2 Nov 2020.